ments of P e d i a t r i c s and Radiology, E a s t Meadow, NY. Acute i n t r a c r a n i a l d i s t u r b a n c e s such a s p e r i v e n t r i c u l a r (PVH), i n t r a v e n t r i c u l a r ( I V H ) , parenchymal hemorrhages (PHI and vent r i c u l a r d i l a t a t i o n (VD) a r e , t h e o r e t i c a l l y , expected t o d i s t u r b t h e hypothalamo-pituitary-thyroid a x i s i n LBW i n f a n t s . T h i s poss i b i l i t y i s p a r t i c u l a r l y t r u e s i n c e b o t h i n t r a c r a n i a l hemorrhage and abnormal v a l u e s o f t h y r o i d hormones a r e common i n LBW i nf a n t s . Thyroid s t a t u s o f 7 1 LBW i n f a n t s who had S t a t e r e c a l l f o r r e p e a t t h y r o i d s c r e e n i n g was t h e s u b j e c t o f t h i s s t u d y i n which we had 30 i n f a n t s w i t h abnormal and 4 1 normal c r a n i a l US.
G e s t a t i o n a l ages ( 2 ) of i n f a n t s w i t h normal US,W and t h e hemorrhage were 31.9, 32.5 and 30.1 wks, r e s p e c t i v e l y .
Comparative hormonal s t a t u s o f t h e groups follows: (~~S E M )
: n Gest(wk) Apgar 5 TSH T4 (~9 % ) FT4 (pg%) T3 (ng%) PVH,IVH,PH 1 4 30.1 6.6 4.0f0.5 8.0+0.5 1.12f0.10 1491537 VD 1 6 32.5 8.2 5.7f1.9 8 . l t 0 . 6 1.14f0.12 101216 Normal US 4 1 31.9 8.0 6.6t1.3 8.6f0.5 1.25i0.07 105f10 There appears t o b e a t r e n d towards a lower TSH ()lu/ml), T4 and F r e e T4 w i t h a n i n c r e a s i n g i n t r a c r a n i a l involvement, y e t t h e v a l u e s a r e n o t s i g n i f i c a n t l y d i f f e r e n t .
The r e s u l t s may be int e r p r e t e d a s a s l i g h t l y l e s s e r a c t i v i t y of hypothalamo-pituitaryt h y r o i d a x i s i n LBW i n f a n t s probably secondary t o t h e f a c t o r s developmental i n n a t u r e and/or n e o n a t a l s i c k n e s s e s . Phenobarbital sodium (PBS) in anticonvulsant dosage has been administered t o high risk newborn prematures in an effort t o prevent intraventricular hemorrhage (IVH). The hypothesis has been that PBS may prevent increases in arterial blood pressure (ABP) and cerebral blood flow (CBF). Using radioactive rnicrospheres, we have assessed the e f f e c t of PBS a t serum concentrations of 24.9 + 5.0 ug/ml on regional CBF during steady s t a t e (SS), during hypovolekic hypotension (HH), during blood reinfusion (RE), and during phenylephrine induced hypertension (PHI in ketamine anesthetized beagle puppies from 24-84 hours of age. There were no significant differences for CBF in steady s t a t e with or without PBS (n=9, n=8), or during moderate HH (ABP decreased 35-40%) with or without PBS (n.9, n=8). With PBS blood flow increased t o all regions during RE (significant in all but cortex and white matter, n=8); controls had similar increases in all regions during RE, significant in all but the thalamus (~9 ) . Blood flow during PH increased in all regions with or without PBS (n=5, n=8). Steady s t a t e ABP was 68.2 + 9.8 mmHg.
ABP after PBS was 42.5 + 8.3 mmHg (p < .01). Thus, in ?he newborn puppy, PBS a t anticonvuiiant concentrations reduced arterial blood pressure but did not alter the response of cerebral blood flow. Its e f f e c t on t h e incidence of periventricular hemorrhages in t h e newborn beagle is under current study. 
t i o n , g u t m o t i l i t y and p e r f u s i o n and t h e number and l o c a t i o n of b a c t e r i a i n t h e bowel. A s t h e s e same f a c t o r s a r e important i n t h e development o f n e c r o t i z i n g e n t e r o c o l i t i s (NEC), we t e s t e d t h e h y p o t h e s i s t h a t b r e a t h Hz
could be a u s e f u l d i a g n o s t i c t o o l i n NEC. NEC was d e f i n e d by t h e presence of c l i n i c a l s i g n s and pneumatosis. Feeding i n t o l e r a n c e e p i s o d e s were defined by t h e absence o f pneumatosis and r a p i d r e s o l u t i o n of c l i n i c a l s i g n s a f t e r being NPO and on a n t i b i o t i c s . Samples were c o l l e c t e d d u r i n g e x p i r a t i o n and analyzed by g a s chromatography. R e s u l t s a r e shown below: a ) 15 i n f a n t s w i t h NEC, b) 12 w i t h f e e d i n g i n t o l e r a n c e , c ) 12 fed but o n a n t i b i o t i c s , and d ) 20 h e a l t h y d u r i n g feedings. I n f a n t s w i t h NEC had h i g h e r l k v e l s NPO AND/OR ANTIBIOTIC HEALTHY t h a n i n f a n t s a l s o on a n t i b i o t i c dFLNONEC,, and/or NPO without NEC. NEC i n f a n t s with u n d e t e c t a b l e H,
:
. l e v e l s (2" f a l s e negativesny were 27 Ion a n t i b i o t i c s and/or NPO s i n c e
.. 'i , -!j b i r t h . These f i n d i n g s s u g g e s t t h a t b r e a t h Hz may be a u s e f u l -0

* : t o o l i n t h e e a r l y d i f f e r e n t i a t i o n o f i n f a n t s w i t h NEC from t h o s e P Y m M ---w i t h feeding i n t o l e r a n c e o r o t h e r
B b d d g a s t r o i n t e s t i n a l d i s o r d e r s .
THE USE OF BARBITURATE THERAPY IN SEVERE PERINATAL
a1390 ASPHYXIA: A RANDOMIZED CONTROLLED TRIAL: Ronald N.
Goldberp, F r e d e r i c k L. Bloom, Charles R. Bauer, Pedro Moscoso. Richard C u r l e s s . Barbara Burke. Eduardo Bancalari. Department of P e d i a t r i c s , U n i v e r s i t y of Miami, Miami, FL. The p o s s i b l e c e r e b r a l s p a r i n g e f f e c t s of t h i o p e n t a l were evaluated in 32 s e v e r e l y asphyxiated neonates assigned t o e i t h e r a t h i o p e n t a l treatment (T) or a c o n t r o l ( C ) group which received s t a n d a r d medical therapy. A l l i n f a n t s r e q u i r e d a s s i s t e d v e n t il a t i o n and had neurologic m a n i f e s t a t i o n s of asphyxia. Two of the following 3 c r i t e r i a were a l s o r e q u i r e d : 1 ) Evidence of f e t a l d i s t r e s s 2 ) 5 ' Apgar <4 and 3) Base Excess <-15 mEq/L a t <1 h r of age. (T) was begun a t a mean of 2 h r s . I t was given a s a c o n s t a n t i n f u s i o n d e l i v e r i n g 30 mg/kg w i t h i n 2 h r s and was continued a t a lower dose f o r 24 h r s . S e i z u r e s occurred i n 76% (T) and 73% (C) a t a mean age of 1.6 and 2.5 h r s , r e s p e c t i v e l y . Hypotension r e q u i r i n g treatment occurred i n 88% (T) and 60% (C). Developmental assessments were performed a t 12 mos. of age or g r e a t e r i n 17 i n f a n t s and a t 6 mos. i n 2. (994) 39(2) 11314 -15.0(8) 3 9 82/79 There were no s i g n i f i c a n t d i f f e r e n c e s i n neurologic, c o g n i t i v e o r motor outcomes between groups. D e t e r i o r a t i n g performance over time was a c o n s i s t e n t trend i n both groups. Treatment of t h e s e v e r e l y asphyxiated neonate with t h i o p e n t a l a t these dosages and p o s t n a t a l age does not appear t o have a c e r e b r a l s p a r i n g e f f e c t , and may be a s s o c i a t e d with s i g n i f i c a n t hypotension. To e v a l u a t e t h e c a r d i o v a s c u l a r e f f e c t s of FPL57231 on t h e e a r l y phase of GBS, paralyzed, mechanically v e n t i l a t e d p i g l e t s received a continuous I V i n f u s i o n of GBS ( 4 x 1 0~ org/kg/min) while a o r t i c (AoP) and pulmonary a r t e r y p r e s s u r e s (Ppa) were measured q 15 min ( I ) . Cardiac output <CO) was measured by thermodilution. Control animals (C) (n=3) (X+SD;wt,3026_r385g;age 10+2d) received only GBS. Treatment a n i n a l s (T) (n=4) (wt,2646+493g;age 1153d) received 1 mg/kg/min x 120' of FPL57231, begining 15' a f t e r i n f u s i o n o f GBS began. ( 
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